Both in Pharmaceuticals
Climb Bio vs Ovid Therapeutics
Over the past year CLYM returned +396.3% and OVID returned +106.0%; their daily moves had a correlation of 0.25.
CLYM +396.3% OVID +106.0%Growth of $1, one year, split-adjusted
| Metric | CLYM | OVID |
|---|---|---|
| Price | $9.33 | $2.74 |
| Market cap | $535.9M | $535.1M |
| Today | −4.31% | +14.17% |
| 1 month | −12.6% | +15.6% |
| 6 months | −23.6% | −1.4% |
| Year to date | +133.3% | +68.1% |
| 1 year | +366.5% | +98.6% |
| Revenue growth (YoY) | — | −88.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −2047.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 338.0× |
| Net cash | $183.1M | $117.2M |
| Dividend yield | — | — |
| Volatility (60d) | 80.8% | 64.9% |
| Short % of float | 25.6% | 10.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).